APO F130 (Fenofibrate (micronized) 130 mg)
Pill imprint APO F130 has been identified as Fenofibrate (micronized) 130 mg.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 130 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO F130
- Strength:
- 130 mg
- Color:
- Green & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
More about fenofibrate
Consumer resources
- Other brands: TriCor, Lofibra, Lipofen, Antara, More (2) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
